InvestorsHub Logo
Followers 26
Posts 2868
Boards Moderated 0
Alias Born 12/05/2021

Re: User-840664 post# 667261

Friday, 01/26/2024 9:40:23 AM

Friday, January 26, 2024 9:40:23 AM

Post# of 700564

Well I'm glad you can at least acknowledge something..


I have always been furious about NWBO shareholders funding Advent. For the shorts Im a pumper and for the longs Im a short. lol

As for approval, no one knows what will happen but the IP is dated, the trial was flawed and the UCLA trials ( owned by UCLA) use a different and more effective formula.

Absolute and complete and utter rubish and BS

You must also know that even if approved, NWBO gets a small royalty from any sales, after Advent's costs- Advent books ALL revenues.


You are making that up. Its unknown what the contract is between the two and therefore you dont know that either.

It is very expensive and the UK market is very small, relatively speaking

. It is expensive still and with production technology increasing the cost will decrease with the help of Flaskworks. The MHRA approval is very important it will pave the way for the FDA and EMA to approve. But I can see that bears now starting to downplay the UK approval as insignificant. There is always something you can BS about.

My assessment is that NWBO is already way over valued based on the best case #s

your assessment is irrelevant and BS. You have zero credibilty.
After DCVAXL approval the market cap should be around $4 billion thats a fair value
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News